Skip to main content

CORRECTION article

Front. Pharmacol., 27 September 2019
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01126

Corrigendum: Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis

This article is a correction to:

  1. Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis

    1. Read original article
Ge Li-Sha&#x;Ge Li-Sha1†Liu Li,&#x;Liu Li2,3†Zhou De-PuZhou De-Pu2Shi Zhe-WeiShi Zhe-Wei2Gu XiaohongGu Xiaohong4Chen Guang-YiChen Guang-Yi2Li JiaLi Jia2Lin Jia-FengLin Jia-Feng2Chu Maoping*Chu Maoping4*Li Yue-Chun*Li Yue-Chun2*
  • 1Department of Pediatric Emergency, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
  • 2Department of Cardiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
  • 3Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China
  • 4Children’s Heart Center and Department of Pediatrics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China

A Corrigendum on
Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.

By Li-Sha G, Li L, De-Pu Z, Zhe-Wei S, Xiaohong G, Guang-Yi C, Jia L, Jia-Feng L, Maoping C and Yue-Chun L (2018) Front. Pharmacol. 9:182. doi: 10.3389/fphar.2018.00182

In the original article, there was a mistake in Figure 5A1 and A2 as published. The incorrect images were erroneously inserted. The corrected Figure 5 appears below.

FIGURE 5
www.frontiersin.org

Figure 5 HE staining on the 72nd day. The heart chambers were shrunken and less interstitial fibroblasts infiltrated after treatment with ivabradine (IVA) in CVMC+IVA group as compared to that in CVMC2 group. (A) Normal control 2 group, (B) Normal+IVA group, (C) CVMC+IVA group, and (D) CVMC2 group.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: coxsackievirus, chronic viral myocarditis, heart rate, ivabradine, cardiomyocyte apoptosis

Citation: Li-Sha G, Li L, De-Pu Z, Zhe-Wei S, Xiaohong G, Guang-Yi C, Jia L, Jia-Feng L, Maoping C and Yue-Chun L (2019) Corrigendum: Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis. Front. Pharmacol. 10:1126. doi: 10.3389/fphar.2019.01126

Received: 14 June 2019; Accepted: 30 August 2019;
Published: 27 September 2019.

Edited and reviewed by: Martin C. Michel, Johannes Gutenberg University Mainz, Germany

Copyright © 2019 Li-Sha, Li, De-Pu, Zhe-Wei, Xiaohong, Guang-Yi, Jia, Jia-Feng, Maoping and Yue-Chun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chu Maoping, chmping@126.com; Li Yue-Chun, liyuechun1980@sina.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.